Skip to content
zameds

Bimatoprost

Sold as Lumigan, Bimatoprost eye pharma-q, Bimatoprost ipharma, Bimagam, Bimapres, Optensin, Optivisan, Oculapres

S4
Loading the molecular structure
C25H37NO4415.60 g/mol

(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide

Drag to rotate. Structure from PubChem CID 5311027.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
5
Registrations
11
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Abbvie (Pty) LtdLumigan0,3 mg/ml360157, 420835S4PIPIL
Pharma-q Holdings (Pty) LtdBimatoprost eye pharma-q0,03 %509951S4None
Ipharma (Pty) LtdBimatoprost ipharmaNot stated530135S4None
Austell Pharmaceuticals (Pty) LtdBimagam, Bimapres0,1 mg, 0,3 mg540317, 540318, 540319.317, 540320.318S4PIPIL
Trinity Pharma (Pty) LtdOptensin, Optivisan, Oculapres0,3 mg540391, 540392.391, 540393.391S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Lumigan 0,03 %

EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg

0,3 mg/mlEye drops36015736/15.4/0157Approved 21 April 2023RegisteredS4PIPIL
Lumigan 0,01 %

EACH 1,0 ml SOLUTION CONTAINS:BIMATOPROST 0,1 mg

0,3 mg/mlEye drops42083542/15.4/0835Approved 21 April 2023RegisteredS4PIPIL
Bimatoprost 0,03 % eye drops pharma-q

Each 1,0 ml of sterile solution contains BIMATOPROST 0,3 mg

0,03 %Drops50995150/15.4/9951RegisteredS4None
Bimatoprost ipharma

EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg

Not listed53013553/15.4/0135RegisteredS4None
Bimagam 0,01 %

EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,1 mg

0,1 mgEye drops54031754/15.4/0317Approved 17 October 2023RegisteredS4PIPIL
Bimagam 0,03%

EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg

0,3 mgEye drops54031854/15.4/0318Approved 17 October 2023RegisteredS4PIPIL
Bimapres 0,01 %

EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,1 mg

0,1 mgEye drops540319.31754/15.4/0319.317Approved 17 October 2023RegisteredS4PIPIL
Bimapres 0,03%

EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg

0,3 mgEye drops540320.31854/15.4/0320.318Approved 17 October 2023Old MedicineS4PIPIL
Optensin

EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg

0,3 mgEye drops, solution54039154/15.4/0391Approved 30 June 2026RegisteredS4PIPIL
Optivisan

EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg

0,3 mgEye drops, solution540392.39154/15.4/0392.391Approved 30 June 2026RegisteredS4PIPIL
Oculapres

EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg

0,3 mgEye drops, solution540393.39154/15.4/0393.391Approved 30 June 2026RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Bimatoprost

  • S4: Bimatoprost

    Consolidated Schedules 06 July 2026, line 5499

Pharmacological class: Others. (class 15.4)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsLumigan 0,03 %, Abbvie (Pty) LtdPatient information leaflet (PIL)For patients and carersLumigan 0,03 %, Abbvie (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles